Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/16/1993 | WO1993009766A1 Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals |
05/16/1993 | CA2121603A1 Antiphlogistic-analgesic plaster |
05/16/1993 | CA2100657A1 Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals |
05/13/1993 | WO1993009176A2 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
05/13/1993 | WO1993009089A1 Bistriazenes as chemotherapeutic agents |
05/13/1993 | WO1993008908A1 Method for producing nanocapsules with cross-linked protein-based walls, nanocapsules thereby obtained, and cosmetic, pharmaceutical and food compositions using same |
05/13/1993 | WO1993008845A1 Localized oligonucleotide therapy |
05/13/1993 | WO1993008841A1 Skin permeation enhancer compositions |
05/13/1993 | WO1993008840A1 Absorption base containing sucrose ester |
05/13/1993 | WO1993008834A1 Vaccine against pathogens of mucosae using liposomes |
05/13/1993 | WO1993008813A1 Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis |
05/13/1993 | WO1993008812A1 Reconstituted platelet membrane vesicles |
05/13/1993 | WO1993008804A1 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
05/13/1993 | WO1993008802A1 Liposome preparation containing tricyclic compound |
05/13/1993 | WO1993008798A1 Pentadimine transdermal composition and patch |
05/13/1993 | WO1993008795A1 Transdermal therapeutic systems containing crystallization inhibitors |
05/13/1993 | WO1993008794A1 Pharmaceutical products for curing tumorous diseases and process for preparing same |
05/13/1993 | WO1993008766A1 Transplant protective coating |
05/13/1993 | WO1993008699A1 Water-soluble delivery systems for hydrophobic liquids |
05/13/1993 | DE4136553A1 Impfstoff gegen schleimhauterreger und herstellungsverfahren Vaccine against pathogen mucosa and manufacturing processes |
05/13/1993 | CA2123007A1 Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration |
05/13/1993 | CA2122480A1 Reconstituted platelet membrane vesicles |
05/13/1993 | CA2122260A1 Method for producing nanocapsules with cross-linked protein-based walls, nanocapsules thereby obtained, and cosmetic, pharmaceutical and food compositions using same |
05/13/1993 | CA2121129A1 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release |
05/13/1993 | CA2082561A1 Antiperspirant materials and compositions |
05/12/1993 | EP0541467A2 Alkyldiamides with two sugar groups as amphiphilic compounds |
05/12/1993 | EP0541369A1 An aqueous dispersion of enteric polymers and a method for producing the same |
05/12/1993 | EP0540969A2 Derivatives of structurally modified VIP and pharmaceutical compositions containing them |
05/12/1993 | EP0540857A1 Process for preparing stable, complexe emulsion compositions of the water-oil-water type and use of said compositions as cosmetic preparations |
05/12/1993 | EP0540813A1 Sustained release formulations of acetazolamide |
05/12/1993 | EP0540747A1 Medicine for intraocular operation |
05/12/1993 | EP0540631A1 Trans-mucosal drug preparations and trans-mucosal administration |
05/12/1993 | EP0540623A1 Oral osmotic device for delivering nicotine. |
05/12/1993 | EP0540576A1 Psychoactive drug and treatment |
05/12/1993 | EP0303713B1 Percutaneous absorption promoter and dermatologic preparation for external use |
05/12/1993 | CN2132502Y Medicine belt for health |
05/12/1993 | CN1071845A Injectable extended release formulations and methods |
05/12/1993 | CN1071836A Pharmaceutical products for curing tumourous diseases and process for preparing same |
05/12/1993 | CN1071832A Pressurised aerosol compositions |
05/11/1993 | US5210099 Analgesic compositions |
05/11/1993 | US5210083 Aqueous solutions containing taurolidine or taurultam and polyol; bactericides |
05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
05/11/1993 | US5210074 Method for preparing a dried composition of insulin-like growth factor i |
05/11/1993 | US5209984 Films of radiation resistant heat sealable polymer blends having a surface adhesion layer grafted thereto |
05/11/1993 | US5209978 For medicines |
05/11/1993 | US5209933 A dihydropyridine compound |
05/11/1993 | US5209932 Foot care compositions |
05/11/1993 | US5209927 Ophthalmic solution |
05/11/1993 | US5209926 Aminosteroids for ophthalmic use |
05/11/1993 | US5209924 Polysiloxane-grafted copolymer topical binder composition with novel fluorochemical comonomer and method of coating therewith |
05/11/1993 | US5209923 Microporous cellulose powders |
05/11/1993 | US5209922 Undecylenic acid salt of quaternized copolymer of vinylpyrrolidone and aminoalkylacrylamide |
05/11/1993 | US5209921 Aerosol compositions |
05/11/1993 | US5209879 Method for inducing transformations in waxes |
05/11/1993 | US5209746 Osmotically driven delivery devices with pulsatile effect |
05/11/1993 | US5209720 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
05/11/1993 | US5209242 Condoms with leading sponges |
05/11/1993 | CA1317550C Dosage form for treating cardiovascular diseases |
05/11/1993 | CA1317548C Freeze-dried pharmaceutical preparations for parenteral use |
05/11/1993 | CA1317547C Anhydrous application form of low molecular alkali huminates |
05/06/1993 | DE4232465A1 Arzneimittel, ihre verwendung und verfahren zu deren herstellung Drugs, their use and processes for their preparation |
05/06/1993 | DE4210711A1 Transdermale therapeutische systeme mit kristallisationsinhibitoren Transdermal therapeutic systems with crystallization inhibitors |
05/05/1993 | EP0540460A1 Novel saccharide-based matrix |
05/05/1993 | EP0540413A1 Vehicle system for an active or a dye allowing an orale administration to fish or to crustaceans |
05/05/1993 | EP0540199A2 Stable water in oil emulsions |
05/05/1993 | EP0539751A1 Biodegradable polymer composition |
05/05/1993 | EP0539627A1 A process for the purification of commercial carrageenins |
05/05/1993 | EP0539457A1 Compositions based on active principles of hydrophobic medicaments solubilizable in an aqueous solvent |
05/05/1993 | EP0539442A1 Enzyme inactivators |
05/05/1993 | EP0539428A1 Compositions containing microparticle matrices |
05/05/1993 | CN1071576A Injectable veterinary composition being free from toxic side effects and process for the preparation thereof |
05/05/1993 | CN1071575A Preparing method for coating agent of complex triamcinolone acetonide acetate |
05/05/1993 | CN1020407C Process for preparation of influenze vaccine |
05/05/1993 | CN1020404C Preparation of corn plaster |
05/04/1993 | US5208256 Treatment of ocular hypertension with a synergistic combination for ocular administration |
05/04/1993 | US5208254 Liver Disorder Treatment |
05/04/1993 | US5208249 Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate |
05/04/1993 | US5208038 Coacervated highly absorptive polymers |
05/04/1993 | US5208037 Dosage forms comprising polymers comprising different molecular weights |
05/04/1993 | US5208036 Complexing a liposomal composition with a quaternary ammonium diether |
05/04/1993 | US5208035 Water Soluble Polymer Base, Penetration Enhancing Agent |
05/04/1993 | US5208031 Sexual lubricants containing zinc as an anti-viral agent |
05/04/1993 | US5208028 Gelled emulsion particles and compositions in which they are present |
05/04/1993 | US5208015 Topical anti-fungal agents having anti-inflammatory activity |
05/04/1993 | US5208011 Ultraviolet resistant sunscreen compositions |
05/04/1993 | US5207998 Octocrylene and titanium dioxide mixture |
05/04/1993 | CA1317287C Cross-linked esters of hyaluronic acid |
05/04/1993 | CA1317227C Composition of matter containing polycarbophil |
05/04/1993 | CA1317226C Viscoelastic fluid for ophthalmic surgery and method of using same |
05/04/1993 | CA1317223C Microencapsulation of biologically active material |
05/04/1993 | CA1317222C Increasing endogenous growth hormone |
05/04/1993 | CA1317171C Plaster, particularly epicutaneous test plaster and process for its production |
05/03/1993 | WO1993008796A1 Self-adhesive for percutaneously absorbable preparation |
05/01/1993 | WO1993008847A1 Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer |
04/29/1993 | WO1993008202A1 Formation of stable liposomes from lipid extracts of archaeobacteria (archaea) |
04/29/1993 | WO1993007903A1 Enhanced skin penetration system for improved topical delivery of drugs |
04/29/1993 | WO1993007902A1 Enhanced skin penetration system for improved topical delivery of drugs |
04/29/1993 | WO1993007901A1 Composition for topical application |
04/29/1993 | WO1993007886A1 Pharmaceutical composition containing certain peptidomimetic compounds |
04/29/1993 | WO1993007875A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |